Detalles de la búsqueda
1.
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.
J Immunol
; 188(2): 714-23, 2012 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22174446
2.
Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
J Virol
; 84(14): 7161-73, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20444898
3.
Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.
J Virol
; 83(2): 791-801, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18971271
4.
Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.
Vaccine
; 36(29): 4346-4353, 2018 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29885769
5.
Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
Virology
; 501: 176-182, 2017 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27936463
6.
Next generation sequencing of DNA-launched Chikungunya vaccine virus.
Virology
; 490: 83-90, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26855330
7.
Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
Vaccine
; 34(13): 1575-1581, 2016 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26868083
8.
Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
Vaccine
; 34(44): 5235-5242, 2016 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27663671
9.
Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.
Virology
; 487: 163-71, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26529299
10.
Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.
Vaccine
; 33(38): 4975-82, 2015 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26207590
11.
Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus.
Virus Res
; 90(1-2): 119-31, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12457968
12.
Cleavage of the hepatitis C virus NS5A protein by caspase-3 in the interferon sensitivity-determining region in a sequence-dependent manner.
Kobe J Med Sci
; 50(5-6): 153-66, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-16049355
13.
Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice.
Virology
; 468-470: 28-35, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25129436
14.
Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia.
Vaccine
; 29(17): 3310-9, 2011 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21382487
15.
Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains.
Vaccine
; 28(23): 3963-71, 2010 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20382241
16.
Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251).
Vaccine
; 25(47): 8021-35, 2007 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-17935840
17.
Hepatitis C virus NS3 protein interacts with ELKS-{delta} and ELKS-{alpha}, members of a novel protein family involved in intracellular transport and secretory pathways.
J Gen Virol
; 86(Pt 8): 2197-2208, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16033967
18.
Physical interaction between hepatitis C virus NS4B protein and CREB-RP/ATF6beta.
Biochem Biophys Res Commun
; 299(3): 366-72, 2002 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-12445808
19.
Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
Microbiol Immunol
; 48(8): 591-8, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15322339
20.
Hepatitis C virus core protein selectively inhibits synthesis and accumulation of p21/Waf1 and certain nuclear proteins.
Microbiol Immunol
; 47(6): 429-38, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12906103